Alharbi, N.S.; Hamdy, N.A.; Aboubakr, E.M.; Alharbi, M.; Ali, M.A.; Alharbi, G.; ElMallah, A.I.
Comparing the Metabolic, Systemic, and Neuropsychiatric Impacts of Olanzapine and Clozapine in Patients with Schizophrenia. Pharmaceuticals 2025, 18, 1314.
https://doi.org/10.3390/ph18091314
AMA Style
Alharbi NS, Hamdy NA, Aboubakr EM, Alharbi M, Ali MA, Alharbi G, ElMallah AI.
Comparing the Metabolic, Systemic, and Neuropsychiatric Impacts of Olanzapine and Clozapine in Patients with Schizophrenia. Pharmaceuticals. 2025; 18(9):1314.
https://doi.org/10.3390/ph18091314
Chicago/Turabian Style
Alharbi, Nayef Samah, Noha Alaa Hamdy, Esam M. Aboubakr, Mansour Alharbi, Mostafa A. Ali, Ghaleb Alharbi, and Ahmed Ibrahim ElMallah.
2025. "Comparing the Metabolic, Systemic, and Neuropsychiatric Impacts of Olanzapine and Clozapine in Patients with Schizophrenia" Pharmaceuticals 18, no. 9: 1314.
https://doi.org/10.3390/ph18091314
APA Style
Alharbi, N. S., Hamdy, N. A., Aboubakr, E. M., Alharbi, M., Ali, M. A., Alharbi, G., & ElMallah, A. I.
(2025). Comparing the Metabolic, Systemic, and Neuropsychiatric Impacts of Olanzapine and Clozapine in Patients with Schizophrenia. Pharmaceuticals, 18(9), 1314.
https://doi.org/10.3390/ph18091314